📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda (2025)

First Author: Olupot-Olupot P
Attributed to:  MICA: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.12688/wellcomeopenres.24096.1

Publication URI: http://dx.doi.org/10.12688/wellcomeopenres.24096.1

Type: Journal Article/Review

Parent Publication: Wellcome Open Research